Ramathibodi Hospital is a university hospital of the Faculty of Medicine Ramathibodi Hospital, Mahidol University. and is a hospital capable of super tertiary care. It is a teaching hospital for all undergraduate students of the Faculty of Medicine Ramathibodi Hospital.

There are 1,300 beds in Ramathibodi Hospital; Medicine/Oncology.

During the past decade, Ramathibodi Hospital; Medicine/Oncology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ramathibodi Hospital; Medicine/Oncology" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Ramathibodi Hospital; Medicine/Oncology" are "Breast Neoplasms" (1 trials), "Cancer" (1 trials), "Cancer of Unknown Primary Site" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Ramathibodi Hospital; Medicine/Oncology" in a lesser frequency.

Most popular intervention types in "Ramathibodi Hospital; Medicine/Oncology" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials), "Gemcitabine" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ramathibodi Hospital; Medicine/Oncology" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Ramathibodi Hospital; Medicine/Oncology". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ramathibodi Hospital; Medicine/Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ramathibodi Hospital; Medicine/Oncology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".